Form 4: Nexxen CFO Sells Shares Under 10b5-1 Plan
Statement of Changes in Beneficial Ownership
Nexxen International Ltd. CFO Niri Sagi reported a sale of 200 common shares for $8.70 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Niri Sagi, Chief Financial Officer of Nexxen International Ltd., sold 200 shares of common stock on June 12, 2026.
- The transaction was executed at a price of $8.70 per share.
- This sale was conducted under a Rule 10b5-1 trading plan adopted on August 19, 2025, which is designed to comply with affirmative defense conditions for insider trading.
- Following the transaction, Niri Sagi beneficially owns 494,850 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While it involves an insider sale, it is conducted under a pre-established Rule 10b5-1 plan, mitigating concerns about opportunistic trading.
Negatives
- Insider selling, even if under a pre-arranged plan, can sometimes be perceived negatively by the market.
Risks
- The Rule 10b5-1 plan is intended to provide an affirmative defense against allegations of insider trading, but its effectiveness relies on strict adherence to its terms and proper adoption procedures.
Future Outlook
The filing itself does not contain forward-looking statements or guidance. The Rule 10b5-1 plan indicates a pre-determined strategy for future transactions.
Management Comments
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 08/19/2025.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan is a common strategy for executives to diversify holdings or manage personal finances without creating the appearance of trading on material non-public information. The specific details of the sale, including the price and quantity, are important for market participants to assess potential insider sentiment.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Niri Sagi appointed attorneys-in-fact (Allison Zolot, Shai Shulman, Maricela Zevala) to execute Section 16 and Form 144 filings on his behalf. | 03/11/2026 | Ensures timely and compliant filing of required SEC documents related to securities holdings and transactions. |
Stakeholder Impact
- Shareholders: May observe the sale, but the Rule 10b5-1 plan context suggests it's a pre-planned event rather than a reaction to negative company news.
- Management: Demonstrates adherence to corporate governance best practices regarding insider trading.
- Employees: The transaction does not directly impact employee stock options or compensation.
Next Steps
- Continued adherence to the Rule 10b5-1 trading plan for any future transactions.
- Monitoring of Niri Sagi's beneficial ownership for any further changes.
Key Dates
| Date | Description |
|---|---|
| 03/11/2026 | Date of execution of Power of Attorney by Sagi Niri. |
| 06/12/2026 | Transaction date for the sale of common stock. |
| 06/15/2026 | Date of signature for the Form 4 filing. |
| 08/19/2025 | Date the Rule 10b5-1 trading plan was adopted. |
Keywords
Niri Sagi, Nexxen International Ltd., Form 4, Insider Trading, Rule 10b5-1, Stock Sale, CFO, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.